课题基金 / 基金详情

Repurposing Metformin for the Prevention of Disease Progression in Precursor Multiple Myeloma

Repurposing Metformin for the Prevention of Disease Progression in Precursor Multiple Myeloma
重新利用二甲双胍预防前体多发性骨髓瘤的疾病进展
批准号:
10471280
负责人:
Catherine Marinac
金额:
$19.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-01 至 2024-02-29
关键词:
AddressAreaBehavioralBiologyBloodBone MarrowCareer Transition AwardCellsClinicalClinical ManagementClinical TrialsComplementDataData CollectionDevelopmentDiseaseDisease ProgressionEarly treatmentEnrollmentEnsureEpidemiologistEtiologyFoundationsGene ExpressionGoalsImmuneIn VitroIndividualInfrastructureInterceptInterventionIntervention StudiesKnowledgeLaboratory StudyLettersMalignant - descriptorMalignant NeoplasmsMeasuresMetabolic PathwayMetforminMonoclonal gammopathy of uncertain significanceMultiple MyelomaNon-Insulin-Dependent Diabetes MellitusOncologistOrganOxidative PhosphorylationPatient observationPatientsPharmaceutical PreparationsPharmacologyPlacebosPlasma Cell NeoplasmPlasma CellsPopulationPositioning AttributePrecancerous ConditionsPreparationPreventionPrevention strategyPropertyRandomizedResearchResearch PersonnelRiskRisk ReductionScientistSerumSurvival RateSymptomsTestingTrainingTraining ActivityTranslatingTumor Markersantitumor effectarmbaseburden of illnesscancer preventioncancer riskcareercareer developmentclinically relevantclinically significantcohortcostcost effectivedesigndisorder preventiondouble-blind placebo controlled trialefficacious interventionefficacy testingenergy balanceepidemiologic dataepidemiologic discoveriesepidemiology studyevidence basefollow-uphigh riskimprovedin vivoinnovationinterestmTOR Signaling Pathwaymilligrammultiple myeloma M Proteinneoplastic cellnon-diabeticnovelnovel strategiespatient populationpatient subsetspremalignantpreventprogramsrecruitreduce symptomsresponsesingle cell sequencingsingle-cell RNA sequencingstandard of caretranscriptomicstumor-immune system interactions

项目摘要

项目成果

Catherine Marinac的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY This Career Transition Award will position the candidate to achieve her career goal of becoming a successful independent investigator in multiple myeloma (MM) prevention. The candidate's current program of research is focused on elucidating the impact of energy balance factors on MM risk and survival. The research proposed in this K22 will focus on monoclonal gammopathy of undetermined significance (MGUS) and smoldering MM (SMM), which are premalignant conditions that progress to MM in a subset of patients for reasons that are poorly understood. Evidence-based strategies are unavailable for preventing the progression of MGUS/SMM to MM, underscoring the importance of research in this area. A promising pharmacologic intervention to reduce the risk of progression of MGUS/SMM to MM is metformin, an inexpensive, safe, and widely-available drug with demonstrated anti-myeloma properties in laboratory and epidemiologic studies. The study hypothesis is that metformin use will be associated with: (1) a significant reduction in clinical symptoms of disease progression, and (2) altered expression of bone marrow niche cells implicated in the malignant transformation of MGUS/SMM to overt MM. To test these hypotheses, we will conduct a 6-month, double-blind placebo- controlled trial enrolling 86 MGUS/SMM patients who currently have no available strategies for cancer risk reduction. The research outlined in this proposal is expected to contribute to a paradigm change in the clinical follow-up of MGUS and SMM, from a watch and wait approach, to a paradigm focused on the prevention and interception of disease progression. The training plan that complements this research will provide the candidate with the depth and breadth of expertise needed to translate etiologic and epidemiologic discoveries into efficacious interventions for MM and precursor MM patients. Specifically, the training is designed to provide advanced knowledge of precursor MM biology, single-cell sequencing approaches, and intervention research in cancer prevention in preparation for an independent career of research focused on the prevention of MM. Together, the innovative research and strategic training activities will promote the career development of the candidate.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prolonged Nightly Fasting as a Behavioral Intervention for Obesity Reduction and the Prevention of Progression in Precursor Multiple Myeloma
  • 批准号:
    10370660
  • 项目类别:
  • 资助金额:
    $20.8万
  • 财政年份:
    2022
  • 负责人:
    Catherine Marinac
  • 依托单位:
Prolonged Nightly Fasting as a Behavioral Intervention for Obesity Reduction and the Prevention of Progression in Precursor Multiple Myeloma
  • 批准号:
    10633083
  • 项目类别:
  • 资助金额:
    $24.47万
  • 财政年份:
    2022
  • 负责人:
    Catherine Marinac
  • 依托单位:
Repurposing Metformin for the Prevention of Disease Progression in Precursor Multiple Myeloma
  • 批准号:
    10039293
  • 项目类别:
  • 资助金额:
    $19.22万
  • 财政年份:
    2020
  • 负责人:
    Catherine Marinac
  • 依托单位:
Repurposing Metformin for the Prevention of Disease Progression in Precursor Multiple Myeloma
  • 批准号:
    10249288
  • 项目类别:
  • 资助金额:
    $19.22万
  • 财政年份:
    2020
  • 负责人:
    Catherine Marinac
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: